91 related articles for article (PubMed ID: 23074239)
1. Inhibition of malonyl-CoA decarboxylase reduces the inflammatory response associated with insulin resistance.
Samokhvalov V; Ussher JR; Fillmore N; Armstrong IK; Keung W; Moroz D; Lopaschuk DG; Seubert J; Lopaschuk GD
Am J Physiol Endocrinol Metab; 2012 Dec; 303(12):E1459-68. PubMed ID: 23074239
[TBL] [Abstract][Full Text] [Related]
2. CD36 inhibition prevents lipid accumulation and contractile dysfunction in rat cardiomyocytes.
Angin Y; Steinbusch LK; Simons PJ; Greulich S; Hoebers NT; Douma K; van Zandvoort MA; Coumans WA; Wijnen W; Diamant M; Ouwens DM; Glatz JF; Luiken JJ
Biochem J; 2012 Nov; 448(1):43-53. PubMed ID: 22780108
[TBL] [Abstract][Full Text] [Related]
3. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation.
Dyck JR; Cheng JF; Stanley WC; Barr R; Chandler MP; Brown S; Wallace D; Arrhenius T; Harmon C; Yang G; Nadzan AM; Lopaschuk GD
Circ Res; 2004 May; 94(9):e78-84. PubMed ID: 15105298
[TBL] [Abstract][Full Text] [Related]
4. Malonyl CoenzymeA decarboxylase regulates lipid and glucose metabolism in human skeletal muscle.
Bouzakri K; Austin R; Rune A; Lassman ME; Garcia-Roves PM; Berger JP; Krook A; Chibalin AV; Zhang BB; Zierath JR
Diabetes; 2008 Jun; 57(6):1508-16. PubMed ID: 18314420
[TBL] [Abstract][Full Text] [Related]
5. Characterization of rat liver malonyl-CoA decarboxylase and the study of its role in regulating fatty acid metabolism.
Dyck JR; Berthiaume LG; Thomas PD; Kantor PF; Barr AJ; Barr R; Singh D; Hopkins TA; Voilley N; Prentki M; Lopaschuk GD
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):599-608. PubMed ID: 10947976
[TBL] [Abstract][Full Text] [Related]
6. Malonyl-CoA decarboxylase inhibition is selectively cytotoxic to human breast cancer cells.
Zhou W; Tu Y; Simpson PJ; Kuhajda FP
Oncogene; 2009 Aug; 28(33):2979-87. PubMed ID: 19543323
[TBL] [Abstract][Full Text] [Related]
7. Phenethyl isothiocyanate suppresses nitric oxide production via inhibition of phosphoinositide 3-kinase/Akt-induced IFN-gamma secretion in LPS-activated peritoneal macrophages.
Okubo T; Washida K; Murakami A
Mol Nutr Food Res; 2010 Sep; 54(9):1351-60. PubMed ID: 20229527
[TBL] [Abstract][Full Text] [Related]
8. Genetic and Pharmacological Inhibition of Malonyl CoA Decarboxylase Does Not Exacerbate Age-Related Insulin Resistance in Mice.
Ussher JR; Fillmore N; Keung W; Zhang L; Mori J; Sidhu VK; Fukushima A; Gopal K; Lopaschuk DG; Wagg CS; Jaswal JS; Dyck JR; Lopaschuk GD
Diabetes; 2016 Jul; 65(7):1883-91. PubMed ID: 27207536
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of heterocyclic malonyl-CoA decarboxylase inhibitors.
Cheng JF; Chen M; Liu B; Hou Z; Arrhenius T; Nadzan AM
Bioorg Med Chem Lett; 2006 Feb; 16(3):695-700. PubMed ID: 16257202
[TBL] [Abstract][Full Text] [Related]
10. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance.
Koves TR; Ussher JR; Noland RC; Slentz D; Mosedale M; Ilkayeva O; Bain J; Stevens R; Dyck JR; Newgard CB; Lopaschuk GD; Muoio DM
Cell Metab; 2008 Jan; 7(1):45-56. PubMed ID: 18177724
[TBL] [Abstract][Full Text] [Related]
11. Tenidap modulates cytoplasmic pH and inhibits anion transport in vitro. II. Inhibition of IL-1 beta production from ATP-treated monocytes and macrophages.
Laliberte R; Perregaux D; Svensson L; Pazoles CJ; Gabel CA
J Immunol; 1994 Sep; 153(5):2168-79. PubMed ID: 8051418
[TBL] [Abstract][Full Text] [Related]
12. Akt mediates the cross-talk between beta-adrenergic and insulin receptors in neonatal cardiomyocytes.
Morisco C; Condorelli G; Trimarco V; Bellis A; Marrone C; Condorelli G; Sadoshima J; Trimarco B
Circ Res; 2005 Feb; 96(2):180-8. PubMed ID: 15591229
[TBL] [Abstract][Full Text] [Related]
13. Valsartan, independently of AT1 receptor or PPARγ, suppresses LPS-induced macrophage activation and improves insulin resistance in cocultured adipocytes.
Iwashita M; Sakoda H; Kushiyama A; Fujishiro M; Ohno H; Nakatsu Y; Fukushima T; Kumamoto S; Tsuchiya Y; Kikuchi T; Kurihara H; Akazawa H; Komuro I; Kamata H; Nishimura F; Asano T
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E286-96. PubMed ID: 22045314
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury.
Ussher JR; Wang W; Gandhi M; Keung W; Samokhvalov V; Oka T; Wagg CS; Jaswal JS; Harris RA; Clanachan AS; Dyck JR; Lopaschuk GD
Cardiovasc Res; 2012 May; 94(2):359-69. PubMed ID: 22436846
[TBL] [Abstract][Full Text] [Related]
15. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression.
Morisco C; Marrone C; Trimarco V; Crispo S; Monti MG; Sadoshima J; Trimarco B
Cardiovasc Res; 2007 Dec; 76(3):453-64. PubMed ID: 17698050
[TBL] [Abstract][Full Text] [Related]
17. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease.
Lopaschuk GD; Stanley WC
Cardiovasc Drugs Ther; 2006 Dec; 20(6):433-9. PubMed ID: 17136490
[TBL] [Abstract][Full Text] [Related]
18. Docosahexaenoic acid attenuates macrophage-induced inflammation and improves insulin sensitivity in adipocytes-specific differential effects between LC n-3 PUFA.
Oliver E; McGillicuddy FC; Harford KA; Reynolds CM; Phillips CM; Ferguson JF; Roche HM
J Nutr Biochem; 2012 Sep; 23(9):1192-200. PubMed ID: 22137266
[TBL] [Abstract][Full Text] [Related]
19. Tissue-specific regulation of malonyl-CoA decarboxylase activity in OLETF rats.
Kim HJ; Zhao ZS; Lee YJ; Shim WS; Kim SK; Ahn CW; Park CW; Lee HC; Cha BS
Diabetes Obes Metab; 2006 Mar; 8(2):175-83. PubMed ID: 16448521
[TBL] [Abstract][Full Text] [Related]
20. High-glucose condition reduces cardioprotective effects of insulin against mechanical stress-induced cell injury.
Teshima Y; Takahashi N; Thuc LC; Nishio S; Nagano-Torigoe Y; Miyazaki H; Ezaki K; Yufu K; Hara M; Nakagawa M; Saikawa T
Life Sci; 2010 Jul; 87(5-6):154-61. PubMed ID: 20600153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
